Pande Atulinsider trades

In SEC Form 4 filings, Pande Atul is listed as Director of Immunovant, Inc. (IMVT). In the last 90 days, Pande Atul sold $64.9K of Immunovant, Inc. (IMVT) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
IMVTImmunovant, Inc.	Director	3	Aug 28

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-28

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
IMVTImmunovant, Inc.	Aug 28	Aug 28	M	1,500	$8.43	$12,645	118,231	Yes	Form 4
IMVTImmunovant, Inc.	Aug 28	Aug 28	S	1,500	$43.27	Sale −$64,905	116,731	Yes	Form 4
IMVTImmunovant, Inc.	Aug 28	Aug 28	M · derivative	1,500	$8.43	$12,645	65,181	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.